Ardelyx Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2026, Ardelyx Inc 's inventory turnover ratio sequentially decreased to 1.46 in the first quarter 2026, unsurprisingly, as the Ardelyx Inc markets continue to deteriorate, and ARDX's faces growing challenges to bring down its inventories. Ardelyx Inc 's average inventory processing period in the Mar 31 2026 quarter, has increased to 250 days, from 205 days, in the Dec 31 2025 quarter.

Within Healthcare sector 263 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1137 in the fourth quarter 2025, to 1186.

ARDX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Ardelyx Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ARDX Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	-4.34 %	-16.24 %	121.23 %	61.93 %	142.29 %
Y / Y Cost of Sales Growth	-60.9 %	-40.6 %	-74.68 %	31.44 %	72.6 %
Inventory Turnover Ratio (TTM)	1.46	1.78	2.03	2.99	3.18
ARDX's Total Ranking	# 1186	# 1137	# 1419	# 738	# 772
Average inventory processing period	250	205	180	122	115
Seq. Inventory Growth	28.25 %	-29.54 %	13.01 %	-6.31 %	12.29 %
Seq. Cost of Sales Growth	-55.65 %	172.45 %	-67.89 %	0.81 %	-32.64 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 71
Healthcare Sector	# 264
Overall Market	# 1186

Inventory Turnover Ratio Statistics
High	Average	Low
3.6	1.96	0.62
(Dec 31 2024)		(Jun 30 2023)

ARDX Company Profile >> Back to ARDX Efficiency Comparisons >> Compare ARDX Inventory Turnover Ratio to its Competitors

Financial Statements
Ardelyx Inc 's Inventories	$ 23 Millions	Visit ARDX's Balance sheet
Ardelyx Inc 's Cost of Revenues TTM	$ 32 Millions	Visit ARDX's Income Statement
What are ARDX's Sales?		Visit ARDX's Sales by Segment

Other Inventory Turnover Ratios
Ardelyx Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ARDX's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ARDX's Competitors
Inventory Turnover Ratio for ARDX's Suppliers
Inventory Turnover Ratio for ARDX's Customers

You may also want to know
ARDX's Sales Growth Rates	ARDX's Pe Price to earnings ratio	ARDX's Receivables Turnover Ratio	ARDX's Stock Quote
ARDX's Net Income Growth Rates	ARDX's Ps Price to Sales ratio	ARDX's Sales per Employee	ARDX's Asset Turnover Ratio
ARDX's Net Margin	ARDX's Pb Price to Book ratio	ARDX's Financial Strength Ratios	ARDX's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
Elite Pharmaceuticals Inc	3.84	$ 71.976 Millions	$ 19 Millions
Escalon Medical Corp	3.79	$ 6.698 Millions	$ 2 Millions
Evolus Inc	3.71	$ 103.000 Millions	$ 28 Millions
Abbvie Inc	3.70	$ 18,420.000 Millions	$ 4,975 Millions
Alpha Teknova Inc	3.69	$ 26.248 Millions	$ 7 Millions
Biocryst Pharmaceuticals Inc	3.67	$ 19.884 Millions	$ 5 Millions
Neuraxis Inc	3.61	$ 0.665 Millions	$ 0 Millions
Mirum Pharmaceuticals Inc	3.50	$ 85.221 Millions	$ 24 Millions
Sonoma Pharmaceuticals Inc	3.46	$ 12.114 Millions	$ 4 Millions
Tandem Diabetes Care Inc	3.45	$ 461.746 Millions	$ 134 Millions
Exelixis Inc	3.41	$ 84.478 Millions	$ 25 Millions
Baxter International Inc	3.37	$ 7,911.000 Millions	$ 2,348 Millions
Gilead Sciences Inc	3.36	$ 6,139.000 Millions	$ 1,825 Millions
Maravai Lifesciences Holdings Inc	3.33	$ 143.875 Millions	$ 43 Millions
Intelligent Bio Solutions Inc	3.31	$ 2.064 Millions	$ 1 Millions
Agilent Technologies inc	3.29	$ 3,418.000 Millions	$ 1,038 Millions
Cadre Holdings inc	3.28	$ 372.000 Millions	$ 113 Millions
Solventum Corporation	3.23	$ 3,363.000 Millions	$ 1,042 Millions
Biofrontera Inc	3.22	$ 8.867 Millions	$ 3 Millions
10x Genomics Inc	3.21	$ 193.000 Millions	$ 60 Millions
Iovance Biotherapeutics inc	3.14	$ 165.941 Millions	$ 53 Millions
Lftd Partners Inc	3.12	$ 28.258 Millions	$ 9 Millions
Prestige Consumer Healthcare Inc	3.11	$ 493.000 Millions	$ 159 Millions
Beyond Air Inc	3.07	$ 6.521 Millions	$ 2 Millions
Bausch Health Companies Inc	3.07	$ 2,987.000 Millions	$ 974 Millions
Indivior Pharmaceuticals Inc	3.03	$ 242.000 Millions	$ 80 Millions
Amneal Pharmaceuticals Inc	3.02	$ 1,868.000 Millions	$ 618 Millions
Logicmark Inc	3.01	$ 3.826 Millions	$ 1 Millions
Mettler toledo International Inc	3.01	$ 1,189.678 Millions	$ 395 Millions
Revvity Inc	3.00	$ 1,151.379 Millions	$ 384 Millions

Date modified: 2026-08-30T14:45:53+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.